Terán M - Search Results

1

Development and Evaluation of ^99mTc Tricarbonyl Complexes Derived from Flutamide with Affinity for Androgen Receptor.

Cardoso ME, Decuadra P, Zeni M, Delfino A, Tejería E, Coppe F, Mesa JM, Daher G, Giglio J, Carrau G, Gamenara D, Alonso O, Terán M, Rey A. Cardoso ME, et al. Among authors: teran m. Molecules. 2023 Jan 13;28(2):820. doi: 10.3390/molecules28020820. Molecules. 2023. PMID: 36677878 Free PMC article.

2

Evaluation of a Labelled Bacteriophage with 99mTc as a Potential Agent for Infection Diagnosis.

Cardoso ME, Fernández L, Tejería E, Esperón P, Terán M. Cardoso ME, et al. Among authors: teran m. Curr Radiopharm. 2016;9(2):137-42. doi: 10.2174/1874471009666160215162023. Curr Radiopharm. 2016. PMID: 26876366

3

Development and characterization of a ^99m Tc-labeled Neuropeptide Y short analog with potential application in breast cancer imaging.

Cardoso ME, Tejería E, Rey Ríos AM, Terán M. Cardoso ME, et al. Among authors: teran m. Chem Biol Drug Des. 2020 Feb;95(2):302-310. doi: 10.1111/cbdd.13644. Epub 2019 Dec 1. Chem Biol Drug Des. 2020. PMID: 31709766

4

Development and characterization of two novel ⁶⁸ Ga-labelled neuropeptide Y short analogues with potential application in breast cancer imaging.

Cardoso ME, Tejería E, Zirbesegger K, Savio E, Terán M, Rey Ríos AM. Cardoso ME, et al. Among authors: teran m. Chem Biol Drug Des. 2021 Jul;98(1):182-191. doi: 10.1111/cbdd.13864. Epub 2021 May 31. Chem Biol Drug Des. 2021. PMID: 33982434

5

[^99m Tc]Tc-HYNIC-EcgDf21: A defensin short analogue with potential application in infection foci imaging.

Terán M, Osorio J, Cardoso E, Tejería E, Paolino A, Reyes AL, Cecchetto G. Terán M, et al. Chem Biol Drug Des. 2023 Mar;101(3):593-604. doi: 10.1111/cbdd.14149. Epub 2022 Sep 28. Chem Biol Drug Des. 2023. PMID: 36138520

6

Biological studies in animal models using [99mTc](CO)3 recombinant annexin V as diagnostic agent of apoptotic processes.

Terán MA, Martínez E, Reyes AL, Paolino A, Vital M, Esperón P, Pacheco JP, Savio E. Terán MA, et al. Nucl Med Biol. 2011 Feb;38(2):279-85. doi: 10.1016/j.nucmedbio.2010.08.007. Epub 2010 Nov 5. Nucl Med Biol. 2011. PMID: 21315284

7

Assessment of the diagnostic value of 99mTc-radiolabelled specific antibodies in experimental hydatidosis.

Gonźalez S, Terán M, León Cabaña E, Savio E, León A, Nieto A. Gonźalez S, et al. Among authors: teran m. Q J Nucl Med. 1996 Jun;40(2):161-9. Q J Nucl Med. 1996. PMID: 8909101

8

Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECD.

Terán M, Savio E, Paolino A, Frier M. Terán M, et al. Eur J Pharm Biopharm. 2004 Mar;57(2):347-52. doi: 10.1016/j.ejpb.2003.11.003. Eur J Pharm Biopharm. 2004. PMID: 15018995

9

Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: in vitro--in vivo studies.

Terán M, Savio E, Paolino A, Frier M. Terán M, et al. BMC Nucl Med. 2005 Oct 18;5:5. doi: 10.1186/1471-2385-5-5. BMC Nucl Med. 2005. PMID: 16232323 Free PMC article.

10

SECOND LATIN AMERICAN INTERCOMPARISON ON INTERNAL DOSE ASSESSMENT.

Rojo A, Puerta N, Gossio S, Gómez Parada I, Cruz Suarez R, López E, Medina C, Lastra Boylan J, Pinheiro Ramos M, Mora Ramírez E, Alves Dos Reis A, Yánez H, Rubio J, Vironneau Janicek L, Somarriba Vanegas F, Puerta Ortiz J, Salas Ramírez M, López Bejerano G, da Silva T, Miri Oliveira C, Terán M, Alfaro M, García T, Angeles A, Duré Romero E, Farias de Lima F. Rojo A, et al. Among authors: teran m. Radiat Prot Dosimetry. 2016 Sep;170(1-4):49-53. doi: 10.1093/rpd/ncv440. Epub 2015 Oct 25. Radiat Prot Dosimetry. 2016. PMID: 26503854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page